Onc Now: The Next Decade of Hepatobiliary and Pancreatic Cancer Care
EMJ Podcast: Insights For Healthcare Professionals
Release Date: 06/24/2026
AMJ Podcast | Episode 9 | Win Ratio in COPD: A New Lens on Trial Endpoints
EMJ Podcast: Insights For Healthcare Professionals
This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. The content contained in this program was jointly developed by AMJ, the speakers, and Sanofi and Regeneron, and is not eligible for continuing medical education (CME) credits. The speakers were compensated by Sanofi and Regeneron in connection with this program. COPD trial outcomes are not all equal, yet conventional endpoints can make it difficult to weigh severe events, exacerbations, lung function, and symptom burden within a single clinical picture. In this AMJ podcast, Sanjay...
info_outline
Revolutionising Prostate Cancer Diagnosis: AI, Genomics, and Population Screening
EMJ Podcast: Insights For Healthcare Professionals
In the final episode, Veeru Kasivisvanathan discusses the future of prostate cancer diagnosis, including AI-assisted MRI interpretation, genomic risk prediction, polygenic risk scores, and the opportunities and challenges of population screening. Discover how precision technologies could reshape prostate cancer care over the next decade. Timestamps: 00:57 – AI and MRI 02:25 – PARADIGM study 02:51 – Large-scale MRI screening 04:56 – Genomics and polygenic risk scores 06:45 – Future optimism of prostate cancer
info_outline
Revolutionising Prostate Cancer Diagnosis: The Overdiagnosis Dilemma
EMJ Podcast: Insights For Healthcare Professionals
Veeru Kasivisvanathan joins host Catherine Glass to discuss how MRI-first pathways have transformed prostate cancer diagnosis. Discover how the landmark PRECISION trial reshaped clinical practice, why targeted biopsy improves diagnostic accuracy, and how clinicians are balancing precision with access as MRI becomes the new standard. Timestamps: 01:05 – Traditional diagnostic approaches 02:55 – PRECISION trial 05:03 – MRI challenges
info_outline
Revolutionising Prostate Cancer Diagnosis: From Random Biopsies to Precision Pathways
EMJ Podcast: Insights For Healthcare Professionals
Veeru Kasivisvanathan joins host Catherine Glass to discuss how MRI-first pathways have transformed prostate cancer diagnosis. Discover how the landmark PRECISION trial reshaped clinical practice, why targeted biopsy improves diagnostic accuracy, and how clinicians are balancing precision with access as MRI becomes the new standard. 01:05 – Traditional diagnostic approaches 02:55 – PRECISION trial 05:03 – MRI challenges
info_outline
Quickfire: Revolutionising Prostate Cancer Diagnosis
EMJ Podcast: Insights For Healthcare Professionals
In this rapid-fire episode, Veeru Kasivisvanathan answers key questions on prostate cancer diagnosis, MRI, prostate biopsy, overdiagnosis, AI, and future innovations. From common misconceptions to emerging technologies, this concise episode delivers expert insights into one of the fastest-evolving areas of urology.
info_outline
Vaccines and Medical Misinformation in the Social Media Age
EMJ Podcast: Insights For Healthcare Professionals
In this episode, Anna Caldwell speaks with paediatric allergist and immunologist Zachary Rubin about the rise of medical misinformation, vaccine hesitancy, and the opportunities and challenges of social media in healthcare. They discuss common allergy myths, how clinicians can effectively communicate evidence-based medicine online, and what patients can do to prepare for the 2026 allergy season.
info_outline
Hema Now: Innovation, Access, and Leadership in Cellular Therapy
EMJ Podcast: Insights For Healthcare Professionals
In this episode of Hema Now, Megan Melody speaks about the evolution of CAR-T cell therapy and its impact on lymphoma care. She explores the major advances that have transformed outcomes for patients with relapsed and refractory disease, the unanswered questions shaping current research, and the practical challenges of building successful cellular therapy programmes. The conversation also covers equitable access to treatment, the role of quality standards and accreditation, personalised approaches to CAR-T therapy, and the importance of...
info_outline
The Rising Burden of Kidney Stones: Recurrence, Disparities, and Future Directions
EMJ Podcast: Insights For Healthcare Professionals
What does the future hold for kidney stone management? In Part 3, David S. Goldfarb explores disparities in care, promising areas of research, and the move towards more personalised approaches to prevention and treatment. He also discusses the impact of climate change on kidney stone risk and shares why he remains optimistic about the future of kidney stone care. Timestamps: 00:46 – Global warming 02:23 – Emerging research/treatments 03:57 – Asymptomatic kidney stones 04:58 – Broad, empiric approach to treatment 08:29 – Occupation as a risk factor for kidney stones 09:56 –...
info_outline
The Rising Burden of Kidney Stones: Prevention Strategies and Clinical Management
EMJ Podcast: Insights For Healthcare Professionals
What are the most effective ways to prevent kidney stones from recurring? In Part 2, David S. Goldfarb discusses evidence-based prevention strategies, including dietary counselling, hydration, and the role of pharmacological therapies.
info_outline
Onc Now: A Lifetime of Progress in Melanoma
EMJ Podcast: Insights For Healthcare Professionals
In this episode of Onc Now, Vernon Sondak reflects on the remarkable evolution of melanoma care over the course of his career. He discusses how breakthroughs in surgery, immunotherapy, targeted therapies, and neoadjuvant treatment have transformed outcomes for patients with melanoma and influenced treatment strategies across oncology. The conversation also explores the challenges of paediatric melanoma, the importance of multidisciplinary collaboration, and the future priorities for melanoma research and patient care. Timestamps: 00:00 –...
info_outlineIn this episode of Onc Now, Stephen Chan, Clinical Professor in the Department of Clinical Oncology at The Chinese University of Hong Kong, explores the evolving landscape of hepatobiliary and pancreatic cancers. From advances in translational science and precision therapies to the challenges of neuroendocrine tumour care, Chan reflects on the progress made in oncology and the breakthroughs still needed. He also discusses his work with the Hand-in-Hand Cancer Foundation, highlighting the importance of education, compassion, and holistic support for patients and their families.
Timestamps:
00:00 – Introduction
01:18 - Current Hepatobiliary and Pancreatic Landscape
03:23 - Translational Science and Patient Outcomes
05:06 - Founding the Hand-in-Hand Cancer Foundation
06:53 - Advances in Precision Cancer Therapies
08:54 – Rising Incidence of Pancreatic Cancer Post COVID-19
10:45 - President of the International Liver Cancer Association
12:46 - Challenges in Neuroendocrine Tumour Care
14:32 - Future Breakthroughs in Cancer Care
16:02 - Three Wishes for Oncology's Future